Vlad Coric's Net Worth
$123 Million
Who is Vlad Coric?
Vlad Coric has an estimated net worth of $123 Million. This is based on reported shares across multiple companies, which include Biohaven Pharmaceutical Holding Co Ltd., Social Capital Suvretta Holdings Corp. I, Revance Therapeutics, Inc., and Biohaven Ltd..
SEC CIK
Vlad Coric's CIK is 0001704317
Past Insider Trading and Trends
2022 was Vlad Coric's most active year for acquiring shares with 48 total transactions. Vlad Coric's most active month to acquire stocks was the month of September. 2022 was Vlad Coric's most active year for disposing of shares, totalling 42 transactions. Vlad Coric's most active month to dispose stocks was the month of September. 2022 saw Vlad Coric paying a total of $10,865,331.02 for 3,789,553 shares, this is the most they've acquired in one year. In 2022 Vlad Coric cashed out on 2,105,681 shares for a total of $15,861,235.02, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Biohaven Pharmaceutical Holding Co Ltd. No price found
Chief Executive OfficerVlad Coric owns 830,891 units of Common Shares. From 2017 to 2022 Vlad Coric acquired a total of 167,850 shares in Biohaven Pharmaceutical Holding Co Ltd., Vlad also disposed a total of 123,345 shares of Biohaven Pharmaceutical Holding Co Ltd. equalling to $16,768,242.58.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -33.33% | -922.94K |
$148.50 | -$137,056,738.50 | 1.85M |
Oct 3
| |||
Form 4
| +46.97% | 12.01K |
$126.07 | -$1,322,260.02 | 37.58K |
Jan 6 - Jan 7
| |||
Form 4
| +30.27% | 5.88K |
$115.55 | -$586,416.25 | 25.28K |
Nov 25
| |||
Form 4
| +52.69% | 6.7K |
$83.38 | -$483,770.76 | 19.41K |
Jan 6
| |||
Form 4
| +100.00% | 5.99K |
$90.14 | -$447,545.10 | 11.97K |
Nov 25
| |||
Form 4
|
—
|
0
|
—
|
—
| 445.99K |
Dec 31
| |||
Form 4
|
∞
| 5.99K |
$52.13 | -$258,825.45 | 5.99K |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 25
| |||
Form 4
| +35.39% | 5K |
$40.22 | $201,100.00 | 19.13K |
Jun 26
| |||
Form 4
| -4.11% | -100.00K |
$50.07 | -$5,008,912.89 | 2.33M |
Scheduled
|
Mar 12 - Mar 14
| ||
Form 4
| -4.55% | -50.00K |
$35.02 | -$1,750,899.79 | 1.05M |
Scheduled
|
May 30 - Jun 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
| -7.89% | -150.00K |
$29.38 | -$4,411,835.44 | 1.75M |
Scheduled
|
Oct 31 - Nov 1
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Social Capital Suvretta Holdings Corp. I (AKLI) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Revance Therapeutics, Inc. (RVNC) Snapshot price: $6.56
InvestorVlad Coric owns 20,784 units of Common Stock which is worth $136,343.04. In the year 2023 Vlad Coric acquired a total of 20,784 shares in Revance Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +259.34% | 15K |
—
|
—
| 20.78K |
May 1
| |||
Form 4
| +11.34% | 589 |
—
|
—
| 5.78K |
May 3
| |||
Form 4
|
∞
| 5.2K |
—
|
—
| 5.2K |
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Biohaven Ltd. (BHVN) Snapshot price: $37
Chief Executive OfficerVlad Coric owns 1,788,417 units of Common Shares which is worth $66,171,429.00 and 1,543,394 units of Common Stock which is worth $57,105,578.00. From 2022 to 2024 Vlad Coric acquired a total of 2,364,186 shares in Biohaven Ltd. at a cost of $18,365,336.02, Vlad also disposed a total of 115,940 shares of Biohaven Ltd. equalling to $869,550.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +7.32% | 121.95K |
$41.00 | $4,999,991.00 | 1.79M |
Apr 22
| |||
Form 4
| +0.02% | 694 |
—
|
—
| 2.91M |
Apr 5
| |||
Form 4
| +0.22% | 6.47K |
—
|
—
| 2.91M |
Mar 8
| |||
Form 4
| +0.56% | 16.17K |
—
|
—
| 2.91M |
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
| +22.33% | 454.55K |
$22.00 | $9,999,990.00 | 2.49M |
Oct 5
| |||
Form 4
| +1.70% | 25.8K |
$15.97 | $411,995.04 | 1.54M |
Oct 31
| |||
Form 4
| +9.56% | 141.93K |
$14.85 | $2,105,772.35 | 1.63M |
Oct 28
| |||
Form 4
| +137.14% | 853.38K |
$10.50 | $8,960,490.00 | 1.48M |
Oct 25
| |||
Form 4/A
|
—
|
0
|
—
|
—
| 569.31K |
Oct 3
| |||
Form 4
| +119.68% | 485.77K |
$10.31 | $5,009,425.05 | 891.65K |
Oct 5
| |||
Form 4/A
| +80.08% | 461.47K |
—
|
—
| 1.04M |
Oct 3
| |||
Form 4
|
∞
| 1.04M |
$4.49 | -$56.37 | 1.04M |
Oct 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||